BARBARA KARRAKER: Open Payments
NPI 1447463914 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,392 in 52 payments from 30 companies in 2025. Trend: 2023 $138 · 2024 $397 · 2025 $1,392
Food & beverage: $1,392
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $274 |
| AstraZeneca Pharmaceuticals LP | 5 | $124 |
| Daiichi Sankyo Inc. | 4 | $100 |
| Incyte Corporation | 4 | $97 |
| Deciphera Pharmaceuticals Inc. | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $61 |
| Caris MPI, Inc. | 2 | $51 |
| PFIZER INC. | 2 | $44 |
| Eisai Inc. | 2 | $44 |
| JAZZ PHARMACEUTICALS INC. | 1 | $37 |
Products named: RYBREVANT, ENHERTU, QINLOCK, NINLARO, MI CANCER SEEK, ERLEADA, MONJUVI, JAKAFI.
Industry payments across GA — which companies pay providers there.
